125results about How to "Aid in diagnosis" patented technology

The invention comprises systems and methods for evaluating changes in the operational efficiency of an HVAC system over time. The climate control system obtains temperature measurements from at least a first location conditioned by the climate system, and status of said HVAC system. One or more processors receives measurements of outside temperatures from at least one source other than said HVAC system and compares said temperature measurements from said first location with expected temperature measurements. The expected temperature measurements are based at least in part upon past temperature measurements.

The invention comprises a system for calculating a value for the effective thermal mass of a building. The climate control system obtains temperature measurements from at least a first location conditioned by the climate system. One or more processors receive measurements of outside temperatures from at least one source other than the control system and compare the temperature measurements from the first location with expected temperature measurements. The expected temperature measurements are based at least in part upon past temperature measurements obtained by said HVAC control system and said outside temperature measurements. The processors then calculate one or more rates of change in temperature at said first location.

The invention comprises systems and methods for evaluating changes in the operational efficiency of an HVAC system over time. The climate control system obtains temperature measurements from at least a first location conditioned by the climate system, and status of said HVAC system. One or more processors receives measurements of outside temperatures from at least one source other than said HVAC system and compares said temperature measurements from said first location with expected temperature measurements. The expected temperature measurements are based at least in part upon past temperature measurements.

A method and a system for monitoring and characterizing a person's heart condition for various medically related purposes. The method includes the steps of (a) acquiring a selected person's acoustic heart signature, (b) acquiring, substantially simultaneously, that same person's electrical heart signature, (c) choosing elements of determined interest from these two acquired signatures and selectively processing and inter- and / or cross-relating such elements, and (d) employing the results of the relating step to create a heart-condition fingerprint useful in the characterization of that person's heart condition. From a systemic point of view, that system includes (a) acoustic and electrical data-gathering devices employable to collect acoustic and electrical data from a person, and (b) processing structure operatively connected to these devices, operable to process and inter- and / or cross-relate data gathered by the devices for the purpose of generating a reportable heart-condition fingerprint of a person from whom such data has been collected.

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gastric cancers (GC).

A method for the automated analysis of digital images, particularly for the purpose of assessing the presence and severity of cancer in breast tissue based on the relative proportions of tubule formations and epithelial cells identified in digital images of histological slides. The method includes the step of generating a property co-occurrence matrix (PCM) from some or all of the pixels in the image, using the properties of local mean and local standard deviation of intensity in neighbourhoods of the selected pixels, and segmenting the image by labelling the selected pixels as belonging to specified classes based upon analysis of the PCM. In this way relatively dark and substantially textured regions representing epithelial cells in the image can be distinguished from lighter and more uniform background regions Other steps include identifying groups of pixels representing duct cells in the image based on intensity, shape and size criteria, dilating those pixels into surrounding groups labelled as epithelial cells by a dimension to correspond to an overall tubule formation, and calculating a metric based on the ratio of the number of duct pixels after such dilation to the total number of duct and epithelial pixels. Other uses for the method could include the analysis of mineral samples containing certain types of crystal formations.